The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

Share Price Information for Argentex Group. (AGFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.40
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.597%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 38.40
AGFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

1 Apr 2020 07:00

RNS Number : 3223I
Argentex Group PLC
01 April 2020
 

 

1 April 2020

Argentex Group PLC

Trading Update

Argentex Group PLC, ("Argentex" or "the Group"), the provider of foreign exchange services to institutions, corporates and high net worth private individuals, today issues a trading update for the 12 months to 31 March 2020.

 

Highlights for Argentex LLP (the Group's FCA regulated trading subsidiary), for the 12 months to 31 March 2020:

· Revenue increased by over 30% to c.£29m (2019: £21.9m)

· Strong client demand maintained during recent volatility

· Continuing rise in customer acquisition, adding 450 new corporate clients

· Robust business model and risk management systems supporting the Group's COVID-19 response

 

Revenue and trading

Argentex is expecting to report a c.30% increase in revenues to c.£29 million for the 12 months to 31 March 2020 (2019: £21.9 million), with Foreign Exchange ("FX") Turnover exceeding £12bn (2019: £10.8bn). The Group continues to experience very strong growth in customer numbers, adding 450 new corporate clients during the period, while corporate clients actively trading increased by 12%.  Following the Group's sustained excellent financial and operational progress, the Board is confident the Group will meet its full year profit expectations.

The Group's robust business model, balance sheet strength and approach to risk mitigation have ensured continuity of service for Argentex's diverse and sophisticated client base throughout the recent unprecedented market conditions resulting from the outbreak of COVID-19.

 

While client demand has grown throughout the period, the currencies traded has remained consistent with historic trends, and at the end of the period over 95% of the LLP's FX portfolio is comprised of Dollar, Sterling or Euro trades. Argentex's revenue composition has maintained historic stability between spot and forward, and furthermore there has been a positive uptake by the Group's professional clients for FX Options products in their commercial hedging. The options book continues to grow organically, and has reached the scale where it is now making a material revenue contribution.

 

COVID-19

Since the outbreak of COVID-19 and consequential government enforced actions, the priority has been to protect the health and safety of employees and their families. In line with government guidelines, Argentex has successfully implemented its Business Continuity Plan, requiring all staff to work remotely.

 

Operationally, Argentex's prudent and proactive approach to risk management and controls has resulted in no change to the trend of historically low levels of bad debt. Management continue to monitor client profiles, activity and macro-economic conditions as part of our rigorous processes, procedures and policies.

 

Harry Adams and Carl Jani, Co-CEOs commented:

 

"While it is too early to ascertain the full ramifications of COVID-19 on markets and corporates alike, the Group's high quality, credit worthy client base, risk framework and disciplined liquidity management positions the Group well in pursuit of its long-term growth objectives. Our continued strong performance underlines the commitment to our growth strategy and proven business model, and we are confident in our ability to deliver our leading FX services and advice to our clients, while generating returns to investors."

 

 

Timing of full year results

 

Following recent, market-wide regulatory communications from the FCA, PRA, FRC and London Stock Exchange regarding financial reporting, the announcement date of Argentex's full year results for the 12 months ending 31 March 2020 will be confirmed in due course.

 

-ENDS-

 

For further information please contact:

Argentex Group PLC

Carl Jani, Harry Adams - Co-CEOs

(Via FTI Consulting)

FTI Consulting (Financial PR)

Ed Berry, Antonia Powell

Telephone: 0203 727 1046

argentex@fticonsulting.com

 

Numis Securities Limited (Nominated Adviser and Broker)

Stephen Westgate, Charlie Farquhar, Laura White, Hugo RubinsteinTelephone: +44 (0) 20 7260 1000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKDBBDBKBFNN
Date   Source Headline
12th Apr 20227:00 amRNSTrading Update
8th Nov 20217:00 amRNSInterim Results
1st Nov 20217:00 amRNSInterim Results Presentations
11th Oct 20217:00 amRNSTrading Statement
27th Aug 20215:21 pmRNSHolding(s) in Company
13th Aug 20212:16 pmRNSHolding(s) in Company
12th Aug 20214:09 pmRNSHolding(s) in Company
12th Aug 20213:09 pmRNSHolding(s) in Company
12th Aug 20213:08 pmRNSHolding(s) in Company
11th Aug 20211:08 pmRNSHolding(s) in Company
11th Aug 20219:41 amRNSDirector/PDMR Shareholding
4th Aug 20216:08 pmRNSResult of AGM
29th Jul 20217:00 amRNSChange to AGM Arrangements
13th Jul 202112:04 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
5th Jul 20212:22 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSFull year results for period ending 31 March 2021
22nd Jun 20217:00 amRNSNotice of Results
11th Jun 20217:00 amRNSDirectorate Change
10th May 20217:00 amRNSManagement team update
12th Apr 20218:00 amRNSExtension of audit partner's tenure & audit tender
6th Apr 20217:00 amRNSTrading Update
26th Feb 20212:58 pmRNSDirector/PDMR Shareholding
17th Feb 20213:12 pmRNSHolding(s) in Company
9th Feb 20212:34 pmRNSHolding(s) in Company
20th Jan 20217:00 amRNSTrading update and Board changes
20th Nov 20207:00 amRNSInterim Results
19th Nov 20204:53 pmRNSHolding(s) in Company
4th Nov 20207:00 amRNSNotice of interim results
12th Oct 20207:00 amRNSDirector Declaration
12th Oct 20207:00 amRNSTrading Statement
6th Oct 20204:40 pmRNSSecond Price Monitoring Extn
6th Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 20204:40 pmRNSSecond Price Monitoring Extn
30th Sep 20204:35 pmRNSPrice Monitoring Extension
21st Sep 20205:50 pmRNSChange of Registered Office
11th Sep 20202:18 pmRNSAGM Statement
7th Sep 20204:36 pmRNSPrice Monitoring Extension
10th Aug 20207:17 amRNSAnnual Report and Notice of Annual General Meeting
3rd Aug 20207:00 amRNSFull year results for period ending 31 March 2020
29th Jul 20204:35 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSNotice of Full Year Results
8th Jul 20205:24 pmRNSHolding(s) in Company
29th Jun 20209:11 amRNSHolding(s) in Company
27th May 20207:00 amRNSArgentex Group announces new headquarters
26th May 20204:40 pmRNSSecond Price Monitoring Extn
26th May 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
1st Apr 20205:40 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.